04/16/2024 3:15 PM | Onconova Therapeutics (Filer) Traws Pharma, Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
04/12/2024 3:11 PM | ORBIMED ADVISORS LLC (Reporting) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3/A | |
04/11/2024 4:41 PM | TPAV, LLC (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3/A | |
04/08/2024 8:37 PM | Onconova Therapeutics (Subject) Traws Pharma, Inc. (Subject) Viriom, Inc. (Filed by)
| Form SC 13D | |
04/03/2024 7:01 PM | Savchuk Nikolay (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:03 PM | CAUTREELS WERNER (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:04 PM | Pauza Charles David (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/03/2024 7:07 PM | Redfield Robert (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 6:50 PM | Savchuk Nikolay (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 6:51 PM | TPAV, LLC (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 6:53 PM | CAUTREELS WERNER (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 6:54 PM | Pauza Charles David (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 6:55 PM | Redfield Robert (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 6:56 PM | ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 6:57 PM | Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer) Viriom, Inc. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 6:59 PM | Dukes Iain D. (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 6:47 PM | Dukes Iain D. (Reporting) Onconova Therapeutics (Issuer) Traws Pharma, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/15/2024 4:36 PM | Fruchtman Steven M (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:40 PM | Guerin Mark Patrick (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 3:48 PM | Fruchtman Steven M (Reporting) Onconova Therapeutics (Subject) Onconova Therapeutics, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024 3:49 PM | Guerin Mark Patrick (Reporting) Onconova Therapeutics (Subject) Onconova Therapeutics, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 4:36 PM | Fruchtman Steven M (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 4:38 PM | Guerin Mark Patrick (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:09 PM | Fruchtman Steven M (Reporting) Onconova Therapeutics (Subject) Onconova Therapeutics, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/27/2023 3:35 PM | Moyo Victor M (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/27/2023 3:41 PM | Moyo Victor M (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 4:00 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 4:52 PM | Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer) STOVER JACK E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:53 PM | Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer) Shoemaker Mary Teresa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:41 PM | MARINO JAMES J (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:43 PM | GROOPMAN JEROME (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:45 PM | MEHTA VIREN (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:47 PM | Clarke Trafford (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:49 PM | Atadja Peter (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:28 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 4:18 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/04/2023 3:42 PM | Fruchtman Steven M (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2023 3:45 PM | Guerin Mark Patrick (Reporting) Onconova Therapeutics (Issuer) Onconova Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/21/2023 3:45 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2023 3:50 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form DEFA14A | |
07/11/2023 11:15 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form EFFECT | |
Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad) A strange new era for mankind is upon us...
And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day.
Elon believes A.I. is advancing so fast... This strange new device to protect us against that A.I. threat... |
06/30/2023 3:46 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/07/2023 3:30 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form DEF 14A | |
06/07/2023 3:35 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form ARS | |
05/15/2023 4:19 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 4:21 PM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023 7:35 AM | Onconova Therapeutics (Filer) Onconova Therapeutics, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |